BRCA1 and metastatic prostate carcinoma: Thus, our objective was to determine the prevalence of somatic BRCA1/2 variants in Portuguese patients with metastatic prostate cancer by analyzing preliminary data from a prospective clinical trial - the Mainstreaming project.